We are live on
!
Find out more
HEC
Hudson Executive Capital Portfolio holdings
AUM
$151M
1-Year Est. Return
60.14%
This Fund
S&P 500
This Quarter
Est. Return
-14.89%
1 Year Est. Return
+60.14%
3 Year Est. Return
+143.92%
5 Year Est. Return
+104.85%
10 Year Est. Return
+677.02%
AUM
$434M
AUM Growth
+$117M
(+37%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
37.85%
Top 10 Holdings %
Top 10 Hldgs %
96.33%
Holding
12
New
5
Increased
6
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$26.8M |
| 2 |
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
|
+$11.7M |
| 3 |
CIT
CIT Group Inc.
CIT
|
+$8M |
| 4 |
CMA
Comerica
CMA
|
+$3.28M |
| 5 |
WWAV
The WhiteWave Foods Company
WWAV
|
+$2.64M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.05% |
| 2 | Healthcare | 13.78% |
| 3 | Consumer Staples | 7.35% |
| 4 | Technology | 5.52% |
Similar funds
SHF
FWM
CCM
DIG
BDS
MWA
WBCM
CAM
Hudson Executive Capital's Q1 2016 Portfolio in Review
As of Q1 2016, Hudson Executive Capital held 12 positions worth $434M, up 37% from $317M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Hudson Executive Capital deployed $164M of net new capital in Q1 2016, opening 5 new positions and adding to 6 existing holdings. Its largest new stake was Eagle Pharmaceuticals, Inc.: 422,000 shares worth $17.1M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Staples.
- Hudson Executive Capital's largest Q1 2016 buy was Eagle Pharmaceuticals, Inc.: 422,000 shares worth $17.1M.
- Hudson Executive Capital added most to HEARTWARE INTERNATIONAL INC COM STK (DE) in Q1 2016, an estimated $11.7M increase.
- Hudson Executive Capital's ten largest holdings make up 96% of its $434M portfolio in Q1 2016.
- Hudson Executive Capital opened 5 new positions and closed 0 in Q1 2016.
- Hudson Executive Capital's portfolio value rose 37% quarter-over-quarter to $434M.
Based on Hudson Executive Capital's 13F filing for Q1 2016, filed 16 May 2016.